KPIs & Operating Metrics(New)
Growth Metrics

Tenet Healthcare (THC) Gains from Investment Securities (2016 - 2026)

Tenet Healthcare (THC) has disclosed Gains from Investment Securities for 18 consecutive years, with $8.0 million as the latest value for Q1 2026.

  • For Q1 2026, Gains from Investment Securities rose 260.0% year-over-year to $8.0 million; the TTM value through Mar 2026 reached $19.0 million, up 11.76%, while the annual FY2025 figure was $6.0 million, 68.42% down from the prior year.
  • Gains from Investment Securities hit $8.0 million in Q1 2026 for Tenet Healthcare, up from -$323.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $328.0 million in Q3 2025 and bottomed at -$323.0 million in Q4 2025.
  • Average Gains from Investment Securities over 5 years is $1.6 million, with a median of $6.0 million recorded in 2024.
  • On a YoY basis, Gains from Investment Securities climbed as much as 5366.67% in 2025 and fell as far as 3330.0% in 2025.
  • Tenet Healthcare's Gains from Investment Securities stood at -$19.0 million in 2022, then plummeted by 994.74% to -$208.0 million in 2023, then surged by 104.81% to $10.0 million in 2024, then crashed by 3330.0% to -$323.0 million in 2025, then soared by 102.48% to $8.0 million in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $8.0 million, -$323.0 million, and $328.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.